Tanja Herrler

1 ta ish

BG Hospital Murnau

1. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

   Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder +10

   Maqola202010 iqtibos

   ABIABI:AkademIndex/2026.other.508188